The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Invasive disease free survival and brain metastasis rates in patients treated with neoadjuvant chemotherapy with trastuzumab and pertuzumab.
 
Sonya Chew
No Relationships to Disclose
 
Emanuela Ferraro
No Relationships to Disclose
 
Yuan Chen
No Relationships to Disclose
 
Andrea Veronica Barrio
No Relationships to Disclose
 
Daniel W. Kelly
No Relationships to Disclose
 
Shanu Modi
Honoraria - Daiichi Sankyo/Astra Zeneca; Seagen
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Genentech; GlaxoSmithKline; Lilly; Macrogenics; Puma Biotechnology; Seagen; Zymeworks
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Andrew David Seidman
Honoraria - AstraZeneca; BeyondSpring Pharmaceuticals; Genentech/Roche; Genomic Health; Gilead Sciences; Lilly; Novartis; Pfizer
Consulting or Advisory Role - Affinia Therapeutics; BeyondSpring Pharmaceuticals; Cancer Expert Now; G1 Therapeutics; Genentech/Roche; Gilead/Forty Seven; Incyte; Lilly; Novartis; Pfizer
Speakers' Bureau - Genentech/Roche; Genentech/Roche; Genomic Health; Gilead Sciences; Lilly; Novartis/Pfizer
Research Funding - Bayer; Nektar (Inst); Odonate Therapeutics (Inst)
 
Hannah Yong Wen
No Relationships to Disclose
 
Edi Brogi
No Relationships to Disclose
 
Mark E. Robson
Consulting or Advisory Role - Change HealthCare
Research Funding - AstraZeneca (Inst); Merck (Inst); Pfizer (Inst); Zenith Pharmaceuticals (Inst)
Other Relationship - AstraZeneca; Clinical Care Options; Clinical Education Alliance; MJH Healthcare Holdings, LLC; MyMedEd; Pfizer; Physicans' Education Resource; Research to Practice
(OPTIONAL) Uncompensated Relationships - Artios; Daiichi Sankyo; Epic Sciences; Merck; Pfizer; Tempus; Zenith Pharmaceuticals
 
Chau T. Dang
Consulting or Advisory Role - Daichii Sankyo; Gilead Sciences; Novartis; Pfizer; ROCHE/Genentech; Seagen
Research Funding - Genentech/Roche (Inst); Puma Biotechnology (Inst)
Travel, Accommodations, Expenses - ROCHE/Genentech